"cell lung" trang 4 - tải miễn phí từ tailieunhanh
The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma

The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma
8    84    0
MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer

MEOX1 promotes tumor progression and predicts poor prognosis in human non-small-cell lung cancer
7    82    0
The EMSY gene collaborates with CCND1 in non-small cell lung carcinogenesis

The EMSY gene collaborates with CCND1 in non-small cell lung carcinogenesis
5    64    0
The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review

The role of immune checkpoint inhibitor pembrolizumab in treatment of patients with non small cell lung cancer: Review
7    78    1
Outcome and predicting chemotoxicity in elderly patients with advanced non-small cell lung cancer

Outcome and predicting chemotoxicity in elderly patients with advanced non-small cell lung cancer
5    88    0
Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
8    56    0
Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations

Comparison of the efficacies of firstgeneration epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced nonsmall-cell lung cancer harboring EGFR mutations
7    84    0
LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain

LC-MS based sphingolipidomic study on A549 human lung adenocarcinoma cell line and its taxol-resistant strain
15    95    0
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    54    1
A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer

A single-arm phase II study of nabpaclitaxel for patients with chemorefractory non-small cell lung cancer
6    63    1
A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database
10    66    1
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with nonsquamous non-small cell lung cancer in New Zealand
12    75    1
ALK-rearranged lung squamous cell carcinoma responding to alectinib: A case report and review of the literature

ALK-rearranged lung squamous cell carcinoma responding to alectinib: A case report and review of the literature
5    69    1
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy
9    72    1
Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom

Feasibility and validity of The Health Improvement Network database of primary care electronic health records to identify and characterise patients with small cell lung cancer in the United Kingdom
9    69    1
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis

The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: A systematic review and meta-analysis
9    64    1
Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues

Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues
17    77    1
Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J

Up-regulation of miR-146a increases the sensitivity of non-small cell lung cancer to DDP by downregulating cyclin J
14    62    1
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
8    44    1
Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review

Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: A critical review
9    55    1